Seeking Alpha

Dennis R. Mahon

Dennis R. Mahon
Send Message
View as an RSS Feed
View Dennis R. Mahon's Comments BY TICKER:
Latest  |  Highest rated
  • MannKind: Great Afrezza Word Of Mouth, But Prescriptions Won't Soar Right Away [View article]
    You are so right. I like your ideas Robert... there was a lot of money to be made with $MNKD in the past, and likely more in the future. I sold 40% at $7.50 the other day... may be buying that stake back at the right price. I'm not a natural trader... but this stock has driven me crazy... so a little trading might help me make a little money. So far it's been OK... but I sure should have sold a bunch just before approval of Afrezza. Ah well, live, learn, love Afrezza. My core position is intact. GLTA of course.
    Feb 12, 2015. 02:54 PM | 2 Likes Like |Link to Comment
  • Glu Mobile's 4th Quarter Surprises [View article]
    I remember that game! My kids and other relatives played the Nintendo 64 James Bond game and liked it a LOT. Hopefully, $GLUU will have a worthy game as well. Could be big. Maybe bigger than a Cristiano Ronaldo game would be. We know James Bond... he's sold pretty well over the years.
    Feb 12, 2015. 02:07 PM | 1 Like Like |Link to Comment
  • Glu Mobile's 4th Quarter Surprises [View article]
    I have never heard of Cristiano Ronaldo, so personally I'm not looking forward to THAT. Guess you're talking about soccer... "futbol"... but I'm not sure, could be rugby for all I know. Come on now... maybe a Peyton Manning game for $GLUU... real "Football". But Cristiano Ronaldo... gee... maybe for soccer moms, or I guess the "rest" of the world. Not to be snarky, but "That points to one person... Cristiano Roanaldo"... just seems quite funny. I mean, when I read that comment I was, uh, who... the heck is... that person. Anyway, good luck. Glad you like $GLUU.
    Feb 12, 2015. 02:00 PM | Likes Like |Link to Comment
  • PharmaCyte Biotech (Formerly, Nuvilex): Where, Oh Where Did The Cash Flow Go... [View article]
    "PENNY PICKS" today, 2/11/15... email stock promotion letter...
    part of the disclaimer:

    "Stellar Media’s business model is to receive financial compensation to promote public companies. We have been compensated Twenty five thousand dollars cash via bank wire by a third party, Cream Consulting, LLC, to conduct investor relations advertising and marketing for PMCB. This compensation is a major conflict of interest in our ability to be unbiased regarding ."
    Feb 11, 2015. 10:41 AM | Likes Like |Link to Comment
  • Glu blows away estimates; guidance mixed [View news story]
    Pretty nice report with Katy Perry as the cherry on top!
    Feb 4, 2015. 04:19 PM | 3 Likes Like |Link to Comment
  • MannKind: Great Afrezza Word Of Mouth, But Prescriptions Won't Soar Right Away [View article]
    Thank you again Psycho Analyst. Great information.
    Feb 4, 2015. 09:39 AM | 1 Like Like |Link to Comment
  • MannKind: Great Afrezza Word Of Mouth, But Prescriptions Won't Soar Right Away [View article]
    Psycho, thank you for your response to my question regarding pricing. The SA news release "Sanofli Launches Afrezza" from two days ago had this as the second bullet point:

    Afrezza is priced at $7.54 for a daily dose of 12 units compared to $3.14 for Sanofi's injectable Apidra.

    That's what had me confused. I had read your previous article and did understand that Afrezza would be priced similarly to other fast acting insulins.
    But you can see where this bit of info from SA caused me confusion. I take it SA was wrong with their $7.54 vs $3.14 comparison... maybe not "apples to apples"... and I have no idea what Aprida is or if it's comparable to Afrezza.
    Feb 4, 2015. 07:56 AM | Likes Like |Link to Comment
  • Tonix Shares Looking Attractive As Clinical Programs Advance Forward [View article]
    Ah, we all have to raise money at times. No biggie. Gee I'd hate to short this stock. Good luck in the future.
    Feb 3, 2015. 04:58 PM | Likes Like |Link to Comment
  • MannKind: Great Afrezza Word Of Mouth, But Prescriptions Won't Soar Right Away [View article]
    Here's a question: It was inferred in the SA news yesterday that Afrezza costs twice as much as an injected treatment... so Psycho Analyst... was that an accurate statement... I'm confused about this. Please give us your take on the pricing as you see it thus far. Thanks, and thanks for the fine article.
    Feb 3, 2015. 04:53 PM | Likes Like |Link to Comment
  • Tonix Shares Looking Attractive As Clinical Programs Advance Forward [View article]
    Thanks so much for the article Jason. Hard to believe 25 hours have passed since publication and no comments. Then again, it is a low float stock. I'm long, and encouraged to hang in there.

    I have great hope for TNX-102SL for PTSD as I have a close friend who suffers from this due to military action in the first Gulf War years ago. I've got to see if he can get into the AtEase trial some way.

    Anyway, appreciate your conservative estimates, but things could turn out to be a lot bigger for TNX-102SL. And TNX-201 is also very promising.

    Thanks again and best of luck.
    Jan 28, 2015. 12:28 PM | 3 Likes Like |Link to Comment
  • Second Sight: Initiating Bullish Below IPO Pricing Plus My Interview With CEO Robert Greenberg [View article]
    Thank you Mr. Salazar. Great article which I will need to re-read a couple times. I'm long, and under water at this point... but optimistic. May well add.
    Jan 27, 2015. 02:14 PM | Likes Like |Link to Comment
  • The Provectus PV-10 Dilemma [View article]
    Your choice Serico. I happily hold this stock, and am a follower of Alan Robert Ross... and do not ascribe to many of the views in this article. Take a look at the $PVCT website, read everything at "Trusting Intelligence" regarding $PVCT, and read EVERYTHING on "The Blog"... do your DD... then get back to us. Please let us know if you see any reason to invest... or not.
    Jan 22, 2015. 04:29 PM | 3 Likes Like |Link to Comment
  • Let Me Tell You A Story About Pfizer [View article]
    Great comment, captain. We all thank you for that.

    Wow, if Pfizer's future is dim... alert the media. Someone needs to interview "captain ern" and learn about the coming Pfizer collapse. Jeez.

    Why are we here. Let's recap. We have a potential life saving, life lengthening cancer drug in PV-10 which has shown some amazing results in helping melanoma patients in phases one and two... now moving onto phase three. Let's see... it kills melanoma tumors, does not affect or kill regular cells, has a bystander effect that kills non-injected tumors... gets T-cells motivated to fight... and is a very promising drug for fighting liver and breast CANCERS.

    Yeah, I guess nothing happening here...
    Jan 21, 2015. 04:56 PM | 6 Likes Like |Link to Comment
  • Let Me Tell You A Story About Pfizer [View article]
    The authors' posts are editorial content... like news. It's not an ad. Besides, I rather think the cartoonist might approve of Dominics' work discussing $PVCT and PV-10. Just my opinion. And what are you doing here, JustAnother...
    Jan 21, 2015. 04:34 PM | 2 Likes Like |Link to Comment
  • Let Me Tell You A Story About Pfizer [View article]
    Rose Bengal is not a "food dye"... you don't know what you are talking about or dealing with. Alan Robert Ross does know what he's talking about, as does Dominic Rodrigues. But thanks for your humble opinions that help muddy the waters and allow us to buy cheap shares. I'm surprised that Alan Robert Ross, aka Trust Intelligence, even replies to your posts. Notice Dominic doesn't.

    If you are not long, Keubiko, what are you doing here posting about $PVCT... oh, you might be short. Good luck with that. Well, not really.
    Jan 21, 2015. 04:25 PM | 2 Likes Like |Link to Comment
COMMENTS STATS
436 Comments
347 Likes